Clinical Trial Update: Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies

View source ↗

Summary

This update describes a safety follow-up study assessing cardiovascular events in participants from torcetrapib/atorvastatin studies. The study status is termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Cerebrovascular Disorders

Drugs mentioned

• Torcetrapib (torcetrapib)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Pfizer | Conditions: Cardiovascular Disease, Cerebrovascular Disorders | Status: TERMINATED